SCHEMBL3463898

SCHEMBL3463898

CCCC1(c2ccccc2Cl)C(=O)N(Cc2ccc(F)cc2)Cc2cncn21

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.81
CYP11B1 P15538 3/20 0.34
MITF O75030 1/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SCN9A Q15858 1/20 0.33
OPRM1 P35372 2/20 0.33
OPRK1 P41145 2/20 0.33
OPRL1 P41146 2/20 0.33
POLB P06746 2/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CLPP Q16740 1/20 0.32
MAPK14 Q16539 1/20 0.32
TP53 P04637 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3463896 1.00 CYP11B2 (0.81) CYP11B2CYP11B1MITFPKMHTT
SCHEMBL3464675 0.80 CYP11B2 (0.70) CYP11B2CYP11B1
SCHEMBL3464672 0.80 CYP11B2 (0.70) CYP11B2CYP11B1
SCHEMBL3464837 0.79 CYP11B2 (0.62) CYP11B2CYP11B1
SCHEMBL3464840 0.79 CYP11B2 (0.62) CYP11B2CYP11B1
SCHEMBL3978769 0.78 CYP11B2 (0.54) CYP11B2CYP11B1MITFPKMHTT
SCHEMBL3981385 0.77 CYP11B2 (0.56) CYP11B2CYP11B1MITFPKMHTT
SCHEMBL3984392 0.77 CYP11B2 (0.58) CYP11B2CYP11B1MITFPKMHTT
SCHEMBL4269316 0.74 CYP11B2 (0.53) CYP11B2CYP11B1MITFPKMHTT
SCHEMBL8360550 0.73 CYP11B2 (0.55) CYP11B2CYP11B1NPSR1SCN9AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240641-A1 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors PAPILLON JULIEN 2010-09-23 US disclosed
EP-2029604-A2 ALDOSTERONE SYNTHASE AND/OR 11BETA-HYDROXYLASE INHIBITORS Novartis AG (CH) 2009-03-04 EP disclosed
WO-2007139992-A2 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS NOVARTIS AG (CH) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240641-A1 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors HSD11B1, HSD11B2, CYP11B1 CYP11B2 4/4885CYP11B1 3/4885MITF 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.